Skip to main content

Published locations for First IL-23 blocker, guselkumab, earns FDA approval for psoriasis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. First IL-23 blocker, guselkumab, earns FDA approval for psoriasis

User login

  • Reset your password
  • /content/first-il-23-blocker-guselkumab-earns-fda-approval-psoriasis
  • /edermatologynews/article/142549/psoriasis/first-il-23-blocker-guselkumab-earns-fda-approval
  • /familypracticenews/article/142549/psoriasis/first-il-23-blocker-guselkumab-earns-fda-approval
  • /internalmedicinenews/article/142549/psoriasis/first-il-23-blocker-guselkumab-earns-fda-approval
  • /rheumatologynews/article/142549/psoriasis/first-il-23-blocker-guselkumab-earns-fda-approval
  • /rheumatology/article/142549/psoriasis/first-il-23-blocker-guselkumab-earns-fda-approval-psoriasis
  • /internalmedicine/article/142549/psoriasis/first-il-23-blocker-guselkumab-earns-fda-approval
  • /dermatology/article/142549/psoriasis/first-il-23-blocker-guselkumab-earns-fda-approval-psoriasis
  • /familymedicine/article/142549/psoriasis/first-il-23-blocker-guselkumab-earns-fda-approval-psoriasis
  • /rheumatology/psoriatic-arthritis-resource-center/article/142549/psoriasis/first-il-23-blocker
  • /dermatology/psoriasiscollection/article/142549/psoriasis/first-il-23-blocker-guselkumab-earns-fda
  • /psoriatic-arthritis-icymi/article/142549/psoriasis/first-il-23-blocker-guselkumab-earns-fda-approval